Cargando…
Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease
Recent pharmaceutical trials have demonstrated that slowing or reversing pathology in Alzheimer's disease is likely to be possible only in the earliest stages of disease, perhaps even before significant symptoms develop. Pathology in Alzheimer's disease accumulates for well over a decade b...
Autores principales: | Knight, Michael J., McCann, Bryony, Kauppinen, Risto A., Coulthard, Elizabeth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909770/ https://www.ncbi.nlm.nih.gov/pubmed/27378911 http://dx.doi.org/10.3389/fnagi.2016.00139 |
Ejemplares similares
-
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
por: McGarry, Bryony L., et al.
Publicado: (2017) -
Quantitative T2 mapping of white matter: applications for ageing and cognitive decline
por: Knight, Michael J, et al.
Publicado: (2016) -
Quantitative T(1) and T(2) MRI signal characteristics in the human brain: different patterns of MR contrasts in normal ageing
por: Knight, Michael J., et al.
Publicado: (2016) -
Prospective memory in prodromal Alzheimer's disease: Real world relevance and correlations with cortical thickness and hippocampal subfield volumes
por: Nurdal, Volkan, et al.
Publicado: (2020) -
Magnetic Resonance Relaxation Anisotropy: Physical Principles and Uses in Microstructure Imaging
por: Knight, Michael J., et al.
Publicado: (2017)